About Imagenomix
pharma, ngs, ai, cancer, oncology, lung, brain, melanoma, medical & diagnostic laboratories, hospital & health care, medical practice
Decision Makers at Imagenomix
2 contactsMikhail Teverovskiy
CTO
Travis Wold
Chief Executive Officer
Unlock full contact details including verified emails and LinkedIn profiles
Upgrade to ProSales Outreach Angle
Imagenomix is in healthcare. Healthcare companies prioritize compliance (HIPAA), patient outcomes, and operational efficiency. Lead with regulatory alignment and relevant case studies.
Imagenomix's Position in the StackWho Database
- • Imagenomix is 1 of 1,817 medical practice companies tracked in StackWho.
- • 1,812 medical practice companies in our database have verified decision-maker emails (100% of the cohort).
- • 23,956 companies in New York are in the StackWho database.
- • 886 medical practice companies are in the 1-10 employee range (same size as Imagenomix).
Technology detection from public web signals. Decision-maker contacts compiled from LinkedIn public profiles, company filings, and verified outbound testing. Methodology & sources · Updated July 2026.
Frequently Asked Questions
What technology does Imagenomix use?
Full technology stack data for Imagenomix is available on StackWho.
How do I contact the decision makers at Imagenomix?
StackWho has verified email addresses for 2 decision makers at Imagenomix. Pro members can access direct emails for the CEO, CTO, VP of Engineering, and other key contacts. Use StackWho to reach Imagenomix directly for sales, recruiting, or partnerships.
What industry is Imagenomix in?
Imagenomix operates in the medical practice industry, headquartered in New York, New York, United States. StackWho tracks technology stacks and decision maker contacts for companies across all industries.
Similar medical practice Companies
View allQuest Diagnostics
questdiagnostics.com
Dasa
dasa.com.br
University of Arizona Comprehensive Cancer Center
arizona.edu
Hamad Medical Corporation
hamad.qa
Decision Makers
Mikhail Teverovskiy
CTO
Travis Wold
Chief Executive Officer